Smoking may worsen response to teprotumumab in thyroid eye disease
Smoking is known to worsen thyroid eye disease (TED), and according to a new study, it may worsen the response to treatment with teprotumumab. In this single-center, retrospective cohort study, patients with type 2 TED who started or completed therapy during the data collection period had a reduction in clinical...
Read MoreQuizzes
Contact
© 2024 Med Journal 360™ is a trademark of International Healthcare Media, LLC. All rights Reserved